The biotechnology industry is rapidly evolving, with innovative companies pushing the boundaries of science and medicine. To ...

On Friday, Gilead Sciences, Inc. (GILD) stock saw a modest uptick, ending the day at $84.95 which represents a slight increase of $0.28 or 0.33% from the prior close of $84.67. The stock opened at $84 ...

Gilead Sciences, Inc. (Nasdaq: GILD) today announced the upcoming presentation of new findings from its antiviral research ...

BMO chief investment strategist Brian Belski provided an update on his popular North American Dividend Growth portfolio, ...

Gilead Sciences, Inc. today announced additional data from its pivotal Phase 3 PURPOSE 2 trial (NCT04925752) providing an overview of the efficacy and safety of twice-yearly lenacapavir, the company's ...

Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $77.91, along ...

Dr Reddy's Laboratories on Wednesday said it has tied up with Gilead Sciences for the manufacture and commercialisation of the HIV drug Lenacapavir in India and 120 other countries. The company has ...

Mark Holt serves as Executive Director of Technical Engineering at Gilead Sciences ... long-term planning via portfolio analysis, site selection and employee location consulting.

The most recent trading session ended with Gilead Sciences (GILD) standing at $83.94, reflecting a +0.12% shift from the previouse trading day's closing. The stock outperformed the S&P 500 ...

Phase 3 Real Estate Partners has secured a $90 million loan to refinance a 365,613-square-foot life science portfolio in the Boston and San Diego markets, Commercial Observer has learned. Sumitomo ...

I developed the Yield At a Reasonable Price portfolio, focusing on 40 stocks, higher-yielding ETFs, and options for risk management and growth. Gilead was initially included but later sold as it ...

In addition, the Advanced Portfolio is deepening its reach in the physical sciences, with a particular focus on chemistry and artificial intelligence (AI). "Global challenges related to public ...